';
side-area-logo

Developing oral T-cell immunotherapies to treat cancer patients

VAXIMM is a privately held, clinical-stage biotech company developing innovative cancer treatments
MORE
First-in-class Technology
Promising Clinical Programs
Partnering Opportunities